Britain's Lijie officially announced the acquisition of Mezanson

Recently, British household goods giant Li Jie officially announced that it will buy U.S. infant formula manufacturer Mei Zanchen for $16.6 billion. It also said the move would help the company develop in the Chinese market.
understands that the acquisition is expected to be completed in the third quarter of 2017 and that Lijie plans to make a cash acquisition of Mezanson at $90 per share, with a market valuation of $16.6 billion and a total value of $17.9 billion (including Mezanson's net debt).
, chief executive, said the acquisition of Mezanson was a very important step in helping Lilly become a leader in consumer health. At that time, Mei Zanchen's extensive business coverage will greatly strengthen Li Jie's position in the developing market.
note that after the acquisition, the developing market will account for about 40% of the company's sales and China will become the second largest market. (Health front line)